1
|
Escudero-Cabarcas J, Pineda-Alhucema W, Martinez-Banfi M, Acosta-López JE, Cervantes-Henriquez ML, Mejía-Segura E, Jiménez-Figueroa G, Sánchez-Barros C, Puentes-Rozo PJ, Noguera-Machacón LM, Ahmad M, de la Hoz M, Vélez JI, Arcos-Burgos M, Pineda DA, Sánchez M. Theory of Mind in Huntington's Disease: A Systematic Review of 20 Years of Research. J Huntingtons Dis 2024; 13:15-31. [PMID: 38517797 DOI: 10.3233/jhd-230594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/24/2024]
Abstract
Background People with Huntington's disease (HD) exhibit neurocognitive alterations throughout the disease, including deficits in social cognitive processes such as Theory of Mind (ToM). Objective The aim is to identify methodologies and ToM instruments employed in HD, alongside relevant findings, within the scientific literature of the past two decades. Methods We conducted a comprehensive search for relevant papers in the SCOPUS, PubMed, APA-PsyArticles, Web of Science, Redalyc, and SciELO databases. In the selection process, we specifically focused on studies that included individuals with a confirmed genetic status of HD and investigated ToM functioning in patients with and without motor symptoms. The systematic review followed the PRISMA protocol. Results A total of 27 papers were selected for this systematic review, covering the period from 2003 to 2023. The findings consistently indicate that ToM is globally affected in patients with manifest motor symptoms. In individuals without motor symptoms, impairments are focused on the affective dimensions of ToM. Conclusions Based on our analysis, affective ToM could be considered a potential biomarker for HD. Therefore, it is recommended that ToM assessment be included as part of neuropsychological evaluation protocols in clinical settings. Suchinclusion could aid in the identification of early stages of the disease and provide new opportunities for treatment, particularly with emerging drugs like antisense oligomers. The Prospero registration number for this review is CRD42020209769.
Collapse
Affiliation(s)
- Johana Escudero-Cabarcas
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| | - Wilmar Pineda-Alhucema
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| | - Martha Martinez-Banfi
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| | - Johan E Acosta-López
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| | - Martha L Cervantes-Henriquez
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| | - Elsy Mejía-Segura
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| | - Giomar Jiménez-Figueroa
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| | - Cristian Sánchez-Barros
- Hospital Juaneda Miramar Departamento de Neurofisiología Clínica Palma de Mallorca, Islas Baleares, España
| | - Pedro J Puentes-Rozo
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
- Grupo de Neurociencias del Caribe, Universidad del Atlántico, Barranquilla, Colombia
| | | | - Mostapha Ahmad
- Universidad Simón Bolívar, Facultad de Ciencias de la Salud Barranquilla, Colombia
| | - Moisés de la Hoz
- Universidad Simón Bolívar, Facultad de Ciencias de la Salud Barranquilla, Colombia
| | | | - Mauricio Arcos-Burgos
- Grupo de Investigación en Psiquiatría (GIPSI), Departamento de Psiquiatría, Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
| | - David A Pineda
- Grupo de investigación Neuropsicología y Conducta, Universidad de San Buenaventura, Medellín, Colombia
| | - Manuel Sánchez
- Centro de Inv. e Innovación en Ciencias Sociales, Facultad de ciencias jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla, Colombia
| |
Collapse
|
2
|
Hergert DC, Cimino CR. Predictors of Caregiver Burden in Huntington's Disease. Arch Clin Neuropsychol 2021; 36:1426–1437. [PMID: 33723593 DOI: 10.1093/arclin/acab009] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2020] [Revised: 11/19/2020] [Accepted: 02/10/2021] [Indexed: 01/22/2023] Open
Abstract
OBJECTIVE Huntington's disease (HD) is a genetic neurodegenerative condition that is characterized by cognitive, motor, and psychiatric dysfunction. The purpose of this study was to explore which disease characteristics influence caregiver burden in HD. METHODS Fifty participants with HD and 50 of their caregivers participated in the study at the University of South Florida. Participants were administered a neuropsychological battery, the Unified Huntington's Disease Rating Scale (UHDRS) motor exam, and the Frontal Systems Behavior Scale (FrSBe) self-report. Caregivers completed the Caregiving Appraisal Scale and the FrSBe family-report. RESULTS There were significant correlations between caregiver burden and caregiver age and sex, UHDRS motor scores, cognitive functioning, and self and caregiver-reported FrSBe scores. The significant variables were entered into a regression model and explained 63.1% of the variance in caregiver burden scores. Caregiver age, cognitive functioning, and caregiver-reported FrSBe scores continued to be significant predictors of caregiver burden, whereas the other variables were no longer significant. CONCLUSIONS There were significant relationships between caregiver burden, cognitive functioning, and frontally mediated behaviors, but not motor scores. The results suggest that possible interventions for caregivers may include education to caregivers on how to cope with apathy/executive dysfunction and cognitive decline. Caregiver age was associated with burden, with younger age being associated with increased burden when controlling for symptom severity. This has implications for this population in that HD typically has a younger age of onset than other neurodegenerative diseases and therefore, these caregivers may be particularly at risk for caregiver burden.
Collapse
Affiliation(s)
- Danielle C Hergert
- New Mexico Department of Health, Developmental Disabilities Supports Division, Albuquerque, NM, USA
| | - Cynthia R Cimino
- Deparment of Psychology, University of South Florida, Tampa, FL, USA
| |
Collapse
|
3
|
D'Aurizio G, Migliore S, Curcio G, Squitieri F. Safer Attitude to Risky Decision-Making in Premanifest Huntington's Disease Subjects. Front Psychol 2019; 10:846. [PMID: 31057466 PMCID: PMC6477566 DOI: 10.3389/fpsyg.2019.00846] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2018] [Accepted: 03/29/2019] [Indexed: 01/18/2023] Open
Abstract
Huntington’s disease (HD) is an inherited neurodegenerative disorder characterized by involuntary, jerky movements, incoordination, behavioral changes and subtle executive and cognitive impairment starting before motor symptoms. Our study aimed to assess the risky decision-making process in premanifest (pre) HD subjects, by means Game of Dice Task (GDT). As dependent variables, several GDT outcomes have been taken into consideration. We recruited 30 subjects (15 females) with preHD (i.e., Diagnosis Confidence Level < 4; Total Motor Score < 10), and 21 age, gender and education matched neurologically normal subjects (11 females). GDT is a computer-guided task where subjects are invited to watch the digits on which to bet and to evaluate the related potential risk to win or loss. Our results showed that decision and feedback times were longer in preHD than in neurologically normal group in both disadvantageous and advantageous choices. PreHD subjects provided a greater number of “safe” strategies, taken with longer decision-making time than neurologically normal subjects, showing a reduced propensity to risk. Such behavior, characterized by increased slowness in acting and providing answers, might contribute to delineate a behavioral and cognitive profile in preHD.
Collapse
Affiliation(s)
- Giulia D'Aurizio
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy
| | - Simone Migliore
- Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy
| | - Giuseppe Curcio
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy
| | - Ferdinando Squitieri
- Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy
| |
Collapse
|
4
|
Belardinelli MO, Huenefeldt T, Maffi S, Squitieri F, Migliore S. Effects of stimulus-related variables on mental states recognition in Huntington's disease. Int J Neurosci 2018; 129:563-572. [PMID: 30481084 DOI: 10.1080/00207454.2018.1552691] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
BACKGROUND Cognitive abnormalities in Huntington's Disease (HD) can involve the specific impairment of the social perspective taking as well as difficulties in recognizing others' mental state many years before the onset of motor symptoms. AIMS At the scope of assessing how the difficulties in mental state recognition might be an HD early sign before motor symptoms appear, our study was aimed to investigate how the recognition of others' mental states in HD subjects is moderated by different stimulus related features (gender, difficulty (low, medium, high), and valence (positive, negative, neutral) of the mental states that are to be recognized). METHODS Subjects with premanifest (n = 20) and manifest (n = 40) HD performed the revised 'Reading the Mind in the Eyes Test' and were compared with age-matched healthy controls (HC, 40 subjects per cohort). RESULTS Our results highlight an early impairment in mental state recognition preceding manifest HD symptoms and a deterioration of these abilities with HD progression. Moreover, we found in HD premanifest subjects an impairment concerning the recognition of negative and neutral mental states, as well as of mental states with moderate recognition difficulty. Finally, we found that participant gender did not influence the performance in recognizing others' mental states, while all participants recognized mental states displayed by females more accurately than those displayed by males. CONCLUSIONS We conclude that difficulties in the recognition of complex mental states can be considered as an early sign of HD, before evident behavioral manifestations, and peculiar features of the stimulus influence it.
Collapse
Affiliation(s)
- Marta Olivetti Belardinelli
- a ECONA Interuniversity Centre for Research on Cognitive Processing in Natural and Artificial Systems , Sapienza University , Rome , Italy
| | - Thomas Huenefeldt
- a ECONA Interuniversity Centre for Research on Cognitive Processing in Natural and Artificial Systems , Sapienza University , Rome , Italy
| | - Sabrina Maffi
- b Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo , Italy
| | - Ferdinando Squitieri
- b Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo , Italy
| | - Simone Migliore
- b Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo , Italy
| |
Collapse
|
5
|
Migliore S, D'Aurizio G, Curcio G, Squitieri F. Task-switching abilities in pre-manifest Huntington's disease subjects. Parkinsonism Relat Disord 2018; 60:111-117. [PMID: 30201420 DOI: 10.1016/j.parkreldis.2018.09.007] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Revised: 08/31/2018] [Accepted: 09/04/2018] [Indexed: 01/02/2023]
Abstract
INTRODUCTION Huntington's Disease (HD) cognitive dysfunction occurs before unequivocal motor signs become apparent. The predominant early cognitive abnormal domains may include deficits in psychomotor speed, negative emotion recognition and executive functioning. Our study is aimed to investigate the executive control of cognition in pre-manifest (pre) HD subjects, by means of a task-switching protocol. METHODS We recruited 30 pre-HD subjects and 18 age-, sex- and education-matched Healthy Controls (HC). Subjects were assigned to two experimental groups: 15 pre-HD1 with a Total Motor Score (TMS) ≤4 (far from onset) and 15 pre-HD2 with a 5 ≤ TMS≤9 (near to onset and Diagnostic Confidence Level (DCL) still<4). Two different tasks were performed in rapid and random succession, so that the task was either changed from one trial to the next one (switch trials) or repeated (repetition trials). Switch trials are usually slower than repetitions, causing a so-called Switch Cost (SC). RESULTS Pre-HD subjects had worse performance than HC in the switch and repetition trials, as indicated by increased SC and reaction times. In particular, pre-HD2 showed impaired switching abilities with reaction times slower than pre-HD1 and HC. CONCLUSIONS Our study highlighted a task-switching impairment since HD was still at a pre-manifest stage. Such abnormalities worsen when pre-HD subjects start to show subtle motor manifestations, still nonspecific and insufficient to define the clinical diagnosis of HD (DCL<4). Considering that such abilities have obvious implications for activities of daily living, early cognitive rehabilitation programs addressing such deficits might be useful in the premanifest stage of the disease.
Collapse
Affiliation(s)
- Simone Migliore
- Huntington and Rare Diseases Unit, IRCCS Casa Sollievo della Sofferenza Hospital (Rome CSS-Mendel), Viale Cappuccini, 1, 71013, San Giovanni Rotondo, Italy.
| | - Giulia D'Aurizio
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100, Coppito, AQ, Italy
| | - Giuseppe Curcio
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100, Coppito, AQ, Italy
| | - Ferdinando Squitieri
- Huntington and Rare Diseases Unit, IRCCS Casa Sollievo della Sofferenza Hospital (Rome CSS-Mendel), Viale Cappuccini, 1, 71013, San Giovanni Rotondo, Italy
| |
Collapse
|
6
|
Espinoza FA, Turner JA, Vergara VM, Miller RL, Mennigen E, Liu J, Misiura MB, Ciarochi J, Johnson HJ, Long JD, Bockholt HJ, Magnotta VA, Paulsen JS, Calhoun VD. Whole-Brain Connectivity in a Large Study of Huntington's Disease Gene Mutation Carriers and Healthy Controls. Brain Connect 2018; 8:166-178. [PMID: 29291624 DOI: 10.1089/brain.2017.0538] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Huntington's disease (HD) is an inherited brain disorder characterized by progressive motor, cognitive, and behavioral dysfunctions. It is caused by abnormally large trinucleotide cytosine-adenine-guanine (CAG) repeat expansions on exon 1 of the Huntingtin gene. CAG repeat length (CAG-RL) inversely correlates with an earlier age of onset. Region-based studies have shown that HD gene mutation carrier (HDgmc) individuals (CAG-RL ≥36) present functional connectivity alterations in subcortical (SC) and default mode networks. In this analysis, we expand on previous HD studies by investigating associations between CAG-RL and connectivity in the whole brain, as well as between CAG-dependent connectivity and motor and cognitive performances. We used group-independent component analysis on resting-state functional magnetic resonance imaging scans of 261 individuals (183 HDgmc and 78 healthy controls) from the PREDICT-HD study, to obtain whole-brain resting state networks (RSNs). Regression analysis was applied within and between RSNs connectivity (functional network connectivity [FNC]) to identify CAG-RL associations. Connectivity within the putamen RSN is negatively correlated with CAG-RL. The FNC between putamen and insula decreases with increasing CAG-RL, and also shows significant associations with motor and cognitive measures. The FNC between calcarine and middle frontal gyri increased with CAG-RL. In contrast, FNC in other visual (VIS) networks declined with increasing CAG-RL. In addition to observed effects in SC areas known to be related to HD, our study identifies a strong presence of alterations in VIS regions less commonly observed in previous reports and provides a step forward in understanding FNC dysfunction in HDgmc.
Collapse
Affiliation(s)
- Flor A Espinoza
- 1 Department of Translational Neuroscience, The Mind Research Network , Albuquerque, New Mexico
| | - Jessica A Turner
- 2 Departments of Psychology and Neuroscience, Georgia State University , Atlanta, Georgia
| | - Victor M Vergara
- 1 Department of Translational Neuroscience, The Mind Research Network , Albuquerque, New Mexico
| | - Robyn L Miller
- 1 Department of Translational Neuroscience, The Mind Research Network , Albuquerque, New Mexico
| | - Eva Mennigen
- 1 Department of Translational Neuroscience, The Mind Research Network , Albuquerque, New Mexico
| | - Jingyu Liu
- 1 Department of Translational Neuroscience, The Mind Research Network , Albuquerque, New Mexico
| | - Maria B Misiura
- 2 Departments of Psychology and Neuroscience, Georgia State University , Atlanta, Georgia
| | - Jennifer Ciarochi
- 2 Departments of Psychology and Neuroscience, Georgia State University , Atlanta, Georgia
| | - Hans J Johnson
- 3 Department of Psychiatry, Neurology, Psychological and Brain Sciences, University of Iowa , Iowa City, Iowa
| | - Jeffrey D Long
- 3 Department of Psychiatry, Neurology, Psychological and Brain Sciences, University of Iowa , Iowa City, Iowa.,4 Department of Biostatistics, University of Iowa , Iowa City, Iowa
| | - Henry J Bockholt
- 1 Department of Translational Neuroscience, The Mind Research Network , Albuquerque, New Mexico .,3 Department of Psychiatry, Neurology, Psychological and Brain Sciences, University of Iowa , Iowa City, Iowa
| | | | - Jane S Paulsen
- 3 Department of Psychiatry, Neurology, Psychological and Brain Sciences, University of Iowa , Iowa City, Iowa
| | - Vince D Calhoun
- 1 Department of Translational Neuroscience, The Mind Research Network , Albuquerque, New Mexico .,6 Department of Electrical and Computer Engineering, University of New Mexico , Albuquerque, New Mexico
| |
Collapse
|
7
|
Abstract
Magnetic resonance imaging (MRI) is a noninvasive technique used routinely to image the body in both clinical and research settings. Through the manipulation of radio waves and static field gradients, MRI uses the principle of nuclear magnetic resonance to produce images with high spatial resolution, appropriate for the investigation of brain structure and function.
Collapse
Affiliation(s)
- Sarah Gregory
- Huntington's Disease Research Centre, UCL Institute of Neurology, London, UK.
| | - Rachael I Scahill
- Huntington's Disease Research Centre, UCL Institute of Neurology, London, UK
| | - Geraint Rees
- Huntington's Disease Research Centre, UCL Institute of Neurology, London, UK
| | - Sarah Tabrizi
- Huntington's Disease Research Centre, UCL Institute of Neurology, London, UK
| |
Collapse
|
8
|
Domínguez D JF, Poudel G, Stout JC, Gray M, Chua P, Borowsky B, Egan GF, Georgiou-Karistianis N. Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington's disease: 30 months IMAGE-HD data. Cortex 2017; 92:139-149. [DOI: 10.1016/j.cortex.2017.04.001] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2016] [Revised: 12/16/2016] [Accepted: 04/05/2017] [Indexed: 12/17/2022]
|
9
|
de Diego-Balaguer R, Schramm C, Rebeix I, Dupoux E, Durr A, Brice A, Charles P, Cleret de Langavant L, Youssov K, Verny C, Damotte V, Azulay JP, Goizet C, Simonin C, Tranchant C, Maison P, Rialland A, Schmitz D, Jacquemot C, Fontaine B, Bachoud-Lévi AC. COMT Val158Met Polymorphism Modulates Huntington's Disease Progression. PLoS One 2016; 11:e0161106. [PMID: 27657697 PMCID: PMC5033325 DOI: 10.1371/journal.pone.0161106] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2016] [Accepted: 07/29/2016] [Indexed: 11/19/2022] Open
Abstract
Little is known about the genetic factors modulating the progression of Huntington's disease (HD). Dopamine levels are affected in HD and modulate executive functions, the main cognitive disorder of HD. We investigated whether the Val158Met polymorphism of the catechol-O-methyltransferase (COMT) gene, which influences dopamine (DA) degradation, affects clinical progression in HD. We carried out a prospective longitudinal multicenter study from 1994 to 2011, on 438 HD gene carriers at different stages of the disease (34 pre-manifest; 172 stage 1; 130 stage 2; 80 stage 3; 17 stage 4; and 5 stage 5), according to Total Functional Capacity (TFC) score. We used the Unified Huntington's Disease Rating Scale to evaluate motor, cognitive, behavioral and functional decline. We genotyped participants for COMT polymorphism (107 Met-homozygous, 114 Val-homozygous and 217 heterozygous). 367 controls of similar ancestry were also genotyped. We compared clinical progression, on each domain, between groups of COMT polymorphisms, using latent-class mixed models accounting for disease duration and number of CAG (cytosine adenine guanine) repeats. We show that HD gene carriers with fewer CAG repeats and with the Val allele in COMT polymorphism displayed slower cognitive decline. The rate of cognitive decline was greater for Met/Met homozygotes, which displayed a better maintenance of cognitive capacity in earlier stages of the disease, but had a worse performance than Val allele carriers later on. COMT polymorphism did not significantly impact functional and behavioral performance. Since COMT polymorphism influences progression in HD, it could be used for stratification in future clinical trials. Moreover, DA treatments based on the specific COMT polymorphism and adapted according to disease duration could potentially slow HD progression.
Collapse
Affiliation(s)
- Ruth de Diego-Balaguer
- INSERM U955, Equipe 01 Neuropsychologie Interventionnelle, 94000, Créteil, France
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Université Paris Est, Faculté de Médecine, 94000, Créteil, France
- ICREA, 08010, Barcelona, Spain
- Universitat de Barcelona, Departament de Cognició, Desenvolupament i Psicologia de L’Educació, 08035, Barcelona, Spain
- IDIBELL, Unitat de Cognició i Plasticitat Cerebral, 08907, L’Hospitalet de Llobregat, Spain
- Institut de Neurociència, Universitat de Barcelona, Barcelona, Spain
| | - Catherine Schramm
- INSERM U955, Equipe 01 Neuropsychologie Interventionnelle, 94000, Créteil, France
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Université Paris Est, Faculté de Médecine, 94000, Créteil, France
| | - Isabelle Rebeix
- INSERM-UPMC-CNRS, UMR 7225–1127, Institut Cerveau Moelle-ICM, Hôpital Pitié-Salpêtrière, 74013, Paris, France
- Assistance Publique-Hôpitaux de Paris, Département des Maladies du Système Nerveux, Hôpital Pitié-Salpêtrière, 74013, Paris, France
| | - Emmanuel Dupoux
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Laboratoire de Sciences Cognitives et Psycholinguistique, ENS-EHESS-CNRS, Paris, 75005, France
| | - Alexandra Durr
- INSERM-UPMC-CNRS, UMR 7225–1127, Institut Cerveau Moelle-ICM, Hôpital Pitié-Salpêtrière, 74013, Paris, France
- Assistance Publique-Hôpitaux de Paris, Département de Génétique, Hôpital Pitié-Salpêtrière, 74013, Paris, France
| | - Alexis Brice
- INSERM-UPMC-CNRS, UMR 7225–1127, Institut Cerveau Moelle-ICM, Hôpital Pitié-Salpêtrière, 74013, Paris, France
- Assistance Publique-Hôpitaux de Paris, Département de Génétique, Hôpital Pitié-Salpêtrière, 74013, Paris, France
| | - Perrine Charles
- Assistance Publique-Hôpitaux de Paris, Département de Génétique, Hôpital Pitié-Salpêtrière, 74013, Paris, France
| | - Laurent Cleret de Langavant
- INSERM U955, Equipe 01 Neuropsychologie Interventionnelle, 94000, Créteil, France
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Université Paris Est, Faculté de Médecine, 94000, Créteil, France
- Assistance Publique-Hôpitaux de Paris, Centre de Référence Maladie de Huntington, Service de Neurologie, Hôpital Henri Mondor-Albert Chenevier, 94000, Créteil, France
| | - Katia Youssov
- INSERM U955, Equipe 01 Neuropsychologie Interventionnelle, 94000, Créteil, France
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Université Paris Est, Faculté de Médecine, 94000, Créteil, France
- Assistance Publique-Hôpitaux de Paris, Centre de Référence Maladie de Huntington, Service de Neurologie, Hôpital Henri Mondor-Albert Chenevier, 94000, Créteil, France
| | - Christophe Verny
- CHU d'Angers, Centre de Référence des Maladies Neurogénétiques, Service de Neurologie, 49933, Angers, France
| | - Vincent Damotte
- INSERM-UPMC-CNRS, UMR 7225–1127, Institut Cerveau Moelle-ICM, Hôpital Pitié-Salpêtrière, 74013, Paris, France
- Assistance Publique-Hôpitaux de Paris, Département des Maladies du Système Nerveux, Hôpital Pitié-Salpêtrière, 74013, Paris, France
| | - Jean-Philippe Azulay
- CHU de Marseille—Hôpital de la Timone, Service de Neurologie et Pathologie du Mouvement, 13385, Marseille, France
| | - Cyril Goizet
- CHU de Bordeaux-GH Sud—Hôpital Haut-Lévêque, Service de Neurologie, 33604, Pessac, France
| | - Clémence Simonin
- CHRU de Lille, Service de Neurologie et Pathologie du Mouvement, 59000, Lille, France
- INSERM UMR-S 1172, JPArc, centre de recherche Jean-Pierre-Aubert neurosciences et cancer, Université de Lille, 59000, Lille, France
| | - Christine Tranchant
- CHU de Strasbourg—Hôpital de Hautepierre, Service de Neurologie, 67098, Strasbourg, France
| | - Patrick Maison
- INSERM U955, Equipe 01 Neuropsychologie Interventionnelle, 94000, Créteil, France
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Université Paris Est, Faculté de Médecine, 94000, Créteil, France
- Assistance Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Unité de Recherche Clinique, 94000, Créteil, France
| | - Amandine Rialland
- Assistance Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Unité de Recherche Clinique, 94000, Créteil, France
| | - David Schmitz
- Assistance Publique-Hôpitaux de Paris, Hôpital Henri Mondor, Unité de Recherche Clinique, 94000, Créteil, France
| | - Charlotte Jacquemot
- INSERM U955, Equipe 01 Neuropsychologie Interventionnelle, 94000, Créteil, France
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Université Paris Est, Faculté de Médecine, 94000, Créteil, France
| | - Bertrand Fontaine
- Assistance Publique-Hôpitaux de Paris, Département des Maladies du Système Nerveux, Hôpital Pitié-Salpêtrière, 74013, Paris, France
- Assistance Publique-Hôpitaux de Paris, Département de Génétique, Hôpital Pitié-Salpêtrière, 74013, Paris, France
| | - Anne-Catherine Bachoud-Lévi
- INSERM U955, Equipe 01 Neuropsychologie Interventionnelle, 94000, Créteil, France
- Département d’Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, 75005, Paris, France
- Université Paris Est, Faculté de Médecine, 94000, Créteil, France
- Assistance Publique-Hôpitaux de Paris, Centre de Référence Maladie de Huntington, Service de Neurologie, Hôpital Henri Mondor-Albert Chenevier, 94000, Créteil, France
- * E-mail:
| | | |
Collapse
|
10
|
Dogan I, Eickhoff CR, Fox PT, Laird AR, Schulz JB, Eickhoff SB, Reetz K. Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease. NEUROIMAGE-CLINICAL 2015; 7:640-52. [PMID: 25844318 PMCID: PMC4375786 DOI: 10.1016/j.nicl.2015.02.018] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Revised: 02/19/2015] [Accepted: 02/23/2015] [Indexed: 11/25/2022]
Abstract
Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by a complex neuropsychiatric phenotype. In a recent meta-analysis we identified core regions of consistent neurodegeneration in premanifest HD in the striatum and middle occipital gyrus (MOG). For early manifest HD convergent evidence of atrophy was most prominent in the striatum, motor cortex (M1) and inferior frontal junction (IFJ). The aim of the present study was to functionally characterize this topography of brain atrophy and to investigate differential connectivity patterns formed by consistent cortico-striatal atrophy regions in HD. Using areas of striatal and cortical atrophy at different disease stages as seeds, we performed task-free resting-state and task-based meta-analytic connectivity modeling (MACM). MACM utilizes the large data source of the BrainMap database and identifies significant areas of above-chance co-activation with the seed-region via the activation-likelihood-estimation approach. In order to delineate functional networks formed by cortical as well as striatal atrophy regions we computed the conjunction between the co-activation profiles of striatal and cortical seeds in the premanifest and manifest stages of HD, respectively. Functional characterization of the seeds was obtained using the behavioral meta-data of BrainMap. Cortico-striatal atrophy seeds of the premanifest stage of HD showed common co-activation with a rather cognitive network including the striatum, anterior insula, lateral prefrontal, premotor, supplementary motor and parietal regions. A similar but more pronounced co-activation pattern, additionally including the medial prefrontal cortex and thalamic nuclei was found with striatal and IFJ seeds at the manifest HD stage. The striatum and M1 were functionally connected mainly to premotor and sensorimotor areas, posterior insula, putamen and thalamus. Behavioral characterization of the seeds confirmed that experiments activating the MOG or IFJ in conjunction with the striatum were associated with cognitive functions, while the network formed by M1 and the striatum was driven by motor-related tasks. Thus, based on morphological changes in HD, we identified functionally distinct cortico-striatal networks resembling a cognitive and motor loop, which may be prone to early disruptions in different stages of the disease and underlie HD-related cognitive and motor symptom profiles. Our findings provide an important link between morphometrically defined seed-regions and corresponding functional circuits highlighting the functional and ensuing clinical relevance of structural damage in HD. Pre-HD atrophy seeds showed common functional co-activation with a cognitive network. Modeling of manifest-HD seeds delineated a segregation of a cognitive and motor loop. Behavioral decoding of atrophy seeds confirmed functional segregation of networks. Based on morphometric changes in HD distinct corticostriatal networks were identified. Findings depict functional and ensuing clinical relevance of structural damage in HD.
Collapse
Affiliation(s)
- Imis Dogan
- Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany ; Institute of Neuroscience and Medicine (INM-1, INM-4), Research Center Jülich GmbH, 52425 Jülich, Germany ; JARA - Translational Brain Medicine, Aachen, Jülich, Germany
| | - Claudia R Eickhoff
- Institute of Neuroscience and Medicine (INM-1, INM-4), Research Center Jülich GmbH, 52425 Jülich, Germany ; Department of Psychiatry, Psychotherapy and Psychosomatic, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
| | - Peter T Fox
- Research Imaging Center, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284-7801, USA
| | - Angela R Laird
- Department of Physics, Florida International University, Modesto A. Maidique Campus, CP 204, 11200 SW 8th Street, Miami, FL 33199, USA
| | - Jörg B Schulz
- Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany ; JARA - Translational Brain Medicine, Aachen, Jülich, Germany
| | - Simon B Eickhoff
- Institute of Neuroscience and Medicine (INM-1, INM-4), Research Center Jülich GmbH, 52425 Jülich, Germany ; Institute of Clinical Neuroscience and Medical Psychology, Heinrich-Heine University, Universitätsstr. 1, 40225 Düsseldorf, Germany
| | - Kathrin Reetz
- Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany ; Institute of Neuroscience and Medicine (INM-1, INM-4), Research Center Jülich GmbH, 52425 Jülich, Germany ; JARA - Translational Brain Medicine, Aachen, Jülich, Germany
| |
Collapse
|
11
|
Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington’s disease. J Neurol 2015; 262:859-69. [DOI: 10.1007/s00415-015-7642-6] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2014] [Revised: 01/08/2015] [Accepted: 01/09/2015] [Indexed: 11/27/2022]
|
12
|
Wolf RC, Sambataro F, Vasic N, Depping MS, Thomann PA, Landwehrmeyer GB, Süssmuth SD, Orth M. Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington's disease. Psychol Med 2014; 44:3341-3356. [PMID: 25066491 DOI: 10.1017/s0033291714000579] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND Functional magnetic resonance imaging (fMRI) of multiple neural networks during the brain's 'resting state' could facilitate biomarker development in patients with Huntington's disease (HD) and may provide new insights into the relationship between neural dysfunction and clinical symptoms. To date, however, very few studies have examined the functional integrity of multiple resting state networks (RSNs) in manifest HD, and even less is known about whether concomitant brain atrophy affects neural activity in patients. METHOD Using MRI, we investigated brain structure and RSN function in patients with early HD (n = 20) and healthy controls (n = 20). For resting-state fMRI data a group-independent component analysis identified spatiotemporally distinct patterns of motor and prefrontal RSNs of interest. We used voxel-based morphometry to assess regional brain atrophy, and 'biological parametric mapping' analyses to investigate the impact of atrophy on neural activity. RESULTS Compared with controls, patients showed connectivity changes within distinct neural systems including lateral prefrontal, supplementary motor, thalamic, cingulate, temporal and parietal regions. In patients, supplementary motor area and cingulate cortex connectivity indices were associated with measures of motor function, whereas lateral prefrontal connectivity was associated with cognition. CONCLUSIONS This study provides evidence for aberrant connectivity of RSNs associated with motor function and cognition in early manifest HD when controlling for brain atrophy. This suggests clinically relevant changes of RSN activity in the presence of HD-associated cortical and subcortical structural abnormalities.
Collapse
Affiliation(s)
- R C Wolf
- Center for Psychosocial Medicine,Department of General Psychiatry,University of Heidelberg,Heidelberg,Germany
| | - F Sambataro
- Center for Neuroscience and Cognitive Systems@UniTN,Rovereto,Italy
| | - N Vasic
- Department of Psychiatry and Psychotherapy III,Ulm University,Ulm,Germany
| | - M S Depping
- Center for Psychosocial Medicine,Department of General Psychiatry,University of Heidelberg,Heidelberg,Germany
| | - P A Thomann
- Center for Psychosocial Medicine,Department of General Psychiatry,University of Heidelberg,Heidelberg,Germany
| | | | - S D Süssmuth
- Department of Neurology,Ulm University,Ulm,Germany
| | - M Orth
- Department of Neurology,Ulm University,Ulm,Germany
| |
Collapse
|